29: Jeffrey Weber, MD, PhD: Charting New Territories in Melanoma

29: Jeffrey Weber, MD, PhD: Charting New Territories in Melanoma

Publication date: Feb 12, 2020

In our exclusive interview, Jeffrey S. Weber, MD, PhD, shared with us his journey into the melanoma field and the lessons he has learned along the way, some of the key studies that have significantly impacted his career and clinical practice, and what lies ahead in the melanoma pipeline.

Concepts Keywords
Air Social media
Aluminum Care for melanoma
Antibody Melanoma treatment
Apple Cancer care
Biomarkers Immunogen IQ tumor
Blood Colitis
Boston Melanoma
Brain Vitiligo
Breast Few tumors
Checkmate Non melanoma cancers
Clinical Trial Leukemia
Clyde Common cancer
Colitis Real progressive cancer
Columbus Development aesthetic disease
Cortisol High risk disease
Deadpan Very interesting disease
Dhe Lung cancer
Digital Middle class disease
Emotion Dhe melanoma
Endocrine Metastatic progressive melanoma
Endowed Chair Renal cell cancer
England Melanoma OncLive
Evolution Immunotherapy
Explorer Albums
Facebook Cancer
Frontal Brain Melanoma
Greek RTT
Hippie 9
Hippocrates No One
Hippocratic Oath Medicine
Hippolyta Draft:Melissa Chase
Homogeneous Luann Ryon
Hormone
House Officer
Immunity
Immunogen
Immunotherapy
Infusion
IQ
Israel
Lego
Lenny
Leukemia
Lincoln
Los Angeles
Lung
Lung Cancer
Mab
Malignancy
Mark Green
Melanoma
Melon
Messiah
Metastatic
Mets
Middle Class
Millionaire
Nana
Nib
Nurse Practitioner
Oncology
PhD
Physician
Pipeline
Pituitary
Podcast
Prime
Progressive
Prostate
Radiologist
Regression
Relapse
Renal
San Diego
Scrambling
Shrek
Skepticism
Social Media
Subcutaneous
Swimming
Targeted Therapies
Tea
Texas
Thes
Tide
Toxicity
Trail
Triple Negative
Tumor
Twitter
Unforgettable
Veal
Vitiligo
Wheelchair

Semantics

Type Source Name
disease MESH Melanoma
pathway KEGG Melanoma
drug DRUGBANK Medical air

Similar

Original Article

Leave a Comment

Your email address will not be published. Required fields are marked *